Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,049,000 | 8,601,000 | 4,852,000 | 2,234,000 | 8,288,000 |
| Depreciation Amortization | 9,026,000 | 6,568,000 | 4,353,000 | 2,104,000 | 8,399,000 |
| Income taxes - deferred | 454,000 | 838,000 | 498,000 | -120,000 | 1,953,000 |
| Accounts receivable | 140,000 | N/A | N/A | N/A | -608,000 |
| Other Working Capital | 2,533,000 | -102,000 | 259,000 | 522,000 | -10,362,000 |
| Other Operating Activity | -1,962,000 | -926,000 | 578,000 | -98,000 | 3,784,000 |
| Operating Cash Flow | $20,240,000 | $14,979,000 | $10,540,000 | $4,642,000 | $11,454,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,603,000 | 4,412,000 | 7,983,000 | 5,184,000 | 567,000 |
| PPE Investments | -1,660,000 | -1,062,000 | -608,000 | -250,000 | -1,513,000 |
| Net Acquisitions | -906,000 | -812,000 | -3,169,000 | -3,169,000 | -273,000 |
| Purchase Of Investment | -4,620,000 | -3,646,000 | -3,193,000 | -1,932,000 | -4,128,000 |
| Sale Of Investment | 2,147,000 | 2,001,000 | N/A | 888,000 | 4,737,000 |
| Purchase Sale Intangibles | -222,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 279,000 | 408,000 | 73,000 | 4,000 | 118,000 |
| Investing Cash Flow | $1,843,000 | $1,301,000 | $1,086,000 | $725,000 | $-492,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,720,000 | 3,370,000 | 2,416,000 | 2,098,000 | 5,103,000 |
| Debt Repayment | -6,986,000 | -3,486,000 | -3,481,000 | -3,878,000 | -6,000 |
| Common Stock Issued | 153,000 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -9,000,000 | -5,789,000 | -3,679,000 | -1,430,000 | -1,000,000 |
| Dividend Paid | -6,234,000 | -4,710,000 | -3,159,000 | -1,591,000 | -6,088,000 |
| Other Financing Activity | -13,260,000 | -3,742,000 | -2,419,000 | -1,603,000 | -9,183,000 |
| Financing Cash Flow | $-20,607,000 | $-14,357,000 | $-10,322,000 | $-6,404,000 | $-11,174,000 |
| Exchange Rate Effect | -29,000 | 48,000 | 57,000 | 32,000 | -31,000 |
| Beginning Cash Position | 1,735,000 | 1,735,000 | 1,735,000 | 1,735,000 | 1,978,000 |
| End Cash Position | 3,182,000 | 3,706,000 | 3,096,000 | 730,000 | 1,735,000 |
| Net Cash Flow | $1,447,000 | $1,971,000 | $1,361,000 | $-1,005,000 | $-243,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,240,000 | 14,979,000 | 10,540,000 | 4,642,000 | 11,454,000 |
| Capital Expenditure | -1,660,000 | -1,062,000 | -608,000 | -250,000 | -1,513,000 |
| Free Cash Flow | 18,580,000 | 13,917,000 | 9,932,000 | 4,392,000 | 9,941,000 |